Cumberland Pharmaceuticals reported Q2 2024 revenue of $9.8M. Diluted EPS came in at $0.01.
Trailing eight quarters through Q2 2024
Common questions about Cumberland Pharmaceuticals's Q2 2024 earnings report.
Cumberland Pharmaceuticals (CPIX) reported Q2 2024 earnings on August 6, 2024 after market close.
Cumberland Pharmaceuticals reported revenue of $9.8M and diluted EPS of $0.01 for Q2 2024.
You can read the 10-Q periodic report (0001628280-24-036529) directly on SEC EDGAR. The filing index links above go to sec.gov.